Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17336913 | 1.00 | GAA (0.30) | GAAPOLB | |
| SCHEMBL29487238 | 1.00 | GAA (0.30) | GAAPOLB | |
| SCHEMBL3505602 | 1.00 | GAA (0.30) | GAAPOLB | |
| SCHEMBL17336914 | 1.00 | GAA (0.30) | GAAPOLB | |
| SCHEMBL21436285 | 0.88 | — | — | |
| SCHEMBL1627945 | 0.88 | POLB (0.38) | GAAPOLB | |
| SCHEMBL29487239 | 0.88 | POLB (0.38) | GAAPOLB | |
| SCHEMBL29564894 | 0.88 | POLB (0.38) | GAAPOLB | |
| SCHEMBL30879543 | 0.88 | POLB (0.38) | GAAPOLB | |
| SCHEMBL12919752 | 0.86 | HMGCR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087780-A1 | CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4090453-B1 | MICROCAPSULES COATED WITH A POLYSUCCINIMIDE DERIVATIVE | FIRMENICH & CIE (CH) | 2026-04-29 | — | — | EP | disclosed |
| EP-4713129-A1 | ORGANOSILICON-BASED MICROCAPSULES | Firmenich SA (CH) | 2026-03-25 | — | — | EP | disclosed |
| US-12569821-B2 | Microcapsules coated with a polysuccinimide derivative | FIRMENICH SA (CH) | 2026-03-10 | — | — | US | disclosed |
| EP-4688246-A1 | COACERVATE CORE-SHELL MICROCAPSULES | Firmenich SA (CH) | 2026-02-11 | — | — | EP | disclosed |
| US-20260034034-A1 | COMPOSITE MICROCAPSULES | FIRMENICH & CIE (CH) | 2026-02-05 | — | — | US | disclosed |
| EP-4661689-A1 | MICROPARTICLES CONTAINING ALGAL PROTEINS AND USES THEREOF | Firmenich SA (CH) | 2025-12-17 | — | — | EP | disclosed |
| EP-4651987-A1 | MICROCAPSULES FROM POLYLACTONE BASED PREPOLYMER | Firmenich SA (CH) | 2025-11-26 | — | — | EP | disclosed |
| US-20250345252-A1 | COMPOSITE MICROCAPSULES | FIRMENICH & CIE (CH) | 2025-11-13 | — | — | US | disclosed |
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH & CIE (CH) | 2025-10-30 | — | — | US | disclosed |
| WO-2022207526-A1 | FUNCTIONALIZED CHITOSAN PREPARATION | FIRMENICH SA (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022207542-A1 | ACETOACETYL POLYMER – BASED MICROCAPSULES | FIRMENICH SA (CH) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022171450-A1 | HYBRID MICROCAPSULES COMPRISING LIGNIN PARTICLES | FIRMENICH SA (CH) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022171448-A1 | HYBRID MICROCAPSULES COMPRISING A REGENERATED BIOPOLYMER | FIRMENICH SA (CH) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022136007-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136021-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136008-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-30 | — | — | WO | disclosed |
| US-20220175635-A1 | COMPOSITE MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-09 | — | — | US | disclosed |
| US-20220169954-A1 | CLEAVEABLE MULTI-ALCOHOL-BASED MICROCAPSULES | FIRMENICH & CIE (CH) | 2022-06-02 | — | — | US | disclosed |
| US-20220152571-A1 | POLY(AMIDE-ESTER) MICROCAPSULES | FIRMENICH SA (CH) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034034-A1 | COMPOSITE MICROCAPSULES | S100P, HAMP, PCTP | GAA 2247/4885POLB 3755/4885 |
| US-20220152571-A1 | POLY(AMIDE-ESTER) MICROCAPSULES | PARG, CUTA, PARN | GAA 893/4885POLB 293/4885 |
| US-20220175635-A1 | COMPOSITE MICROCAPSULES | PLIN5, LIPA, PHOSPHO1 | GAA 2774/4885POLB 830/4885 |
| US-12569821-B2 | Microcapsules coated with a polysuccinimide derivative | PAM, ACMSD, PFAS | GAA 3857/4885POLB 757/4885 |
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | PSAP, POLI, PGA5 | GAA 661/4885POLB 200/4885 |
| US-20250345252-A1 | COMPOSITE MICROCAPSULES | PLIN5, LIPA, PHOSPHO1 | GAA 2774/4885POLB 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.